Trexquant Investment LP Aeglea Bio Therapeutics, Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$6.76 - $8.57 $136,045 - $172,471	-20,125 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$7.02 - $9.83 $141,277 - $197,828	20,125 New	20,125 $158,000
Q3 2020 Nov 06, 2020	SELL	$6.51 - $9.33 $89,004 - $127,559	-13,672 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$4.01 - $11.04 $54,824 - $150,938	13,672 New	13,672 $126,000
Q1 2019 May 13, 2019	SELL	$7.6 - $9.4 $117,420 - $145,230	-15,450 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$6.51 - $10.19 $100,579 - $157,435	15,450 New	15,450 $116,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.